Balancing Act: Taking a Harmonised Approach to Medical Device Label Interoperability
In this interview Melissa Finocchio, Director, Product Labeling and Documentation BioMerieux, speaks to Andrea Charles from Pharma IQ about changing trends in product labelling and documentation for medical devices, overcoming barriers to standardisation and BioMerieux's top 3 priorities for 2014 now that the FDA Final Rule on UDIs for medical devices is out.
Pharma IQ: What trends are you witnessing with regards to product labelling and documentation for medic...
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.